Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing of a private ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE